United States · FDA National Drug Code directory

BYSANTI

A source-listed medicine record.

Factual source checks only. This page is not a clinically reviewed monograph. Historical or discontinued records may be included; listing does not confirm approval, current availability or pharmacy stock.

Medicine identity

Source reference
43068-912_d49d59a7-1bab-44a6-9d19-4b5635a3f378
Product NDC
43068-912
Form
KIT
Composition / generic term
MILSAPERIDONE
Labeler
Vanda Pharmaceuticals Inc.
Marketing category
NDA
Marketing start / end (source format)
20260701
Source listing expiry
20271231

Source-listed ingredients

Separate ingredient quantities are not available in this snapshot. Any composition term above is preserved as source text.

These values do not establish equivalence or a dose recommendation.

Packages

  • 2 CARTON in 1 BLISTER PACK (43068-912-08) / 1 KIT in 1 CARTON · 43068-912-08

Source and coverage

Open FDA National Drug Code directory

Snapshot retrieved: 2026-09-17. This is the acquisition date, not a medical review date.

Clinical information, images and comparisons appear only when separately reviewed for this record. Coverage may be incomplete. Ask a pharmacist or clinician about your treatment.

Browse United States records →